IMB5476, a novel microtubule inhibitor, induces mitotic catastrophe and overcomes multidrug resistance in tumors
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
IMB5476, a novel microtubule inhibitor, induces mitotic catastrophe and overcomes multidrug resistance in tumors
Authors
Keywords
Angiogenesis, Microtubule inhibitor, Mitotic catastrophe, Multidrug resistance, Nitrobenzoate
Journal
EUROPEAN JOURNAL OF PHARMACOLOGY
Volume 919, Issue -, Pages 174802
Publisher
Elsevier BV
Online
2022-02-08
DOI
10.1016/j.ejphar.2022.174802
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hydroxyurea and Caffeine Impact pRb-like Protein-Dependent Chromatin Architecture Profiles in Interphase Cells of Vicia Faba
- (2021) Marcelina W. Musiałek et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Clinically-Relevant ABC Transporter for Anti-Cancer Drug Resistance
- (2021) Huan Xiao et al. Frontiers in Pharmacology
- Second-Generation Antimitotics in Cancer Clinical Trials
- (2021) Pedro Novais et al. Pharmaceutics
- Microtubule associated proteins as targets for anticancer drug development
- (2021) Sadiya Khwaja et al. BIOORGANIC CHEMISTRY
- Two-Phase Synthesis of Taxol
- (2020) Yuzuru Kanda et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Recent advances in trimethoxyphenyl (TMP) based tubulin inhibitors targeting the colchicine binding site
- (2018) Ling Li et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- A CD13-targeting peptide integrated protein inhibits human liver cancer growth by killing cancer stem cells and suppressing angiogenesis
- (2017) Yan-Bo Zheng et al. MOLECULAR CARCINOGENESIS
- Phase 1 Study of ABT-751 in Combination With CAPIRI (Capecitabine and Irinotecan) and Bevacizumab in Patients With Advanced Colorectal Cancer
- (2016) Michelle A. Rudek et al. JOURNAL OF CLINICAL PHARMACOLOGY
- A Novel Nitrobenzoate Microtubule Inhibitor that Overcomes Multidrug Resistance Exhibits Antitumor Activity
- (2016) Yan-Bo Zheng et al. Scientific Reports
- Total Synthesis of Vinblastine, Related Natural Products, and Key Analogues and Development of Inspired Methodology Suitable for the Systematic Study of Their Structure–Function Properties
- (2015) Justin E. Sears et al. ACCOUNTS OF CHEMICAL RESEARCH
- Antimitotic drugs in the treatment of cancer
- (2015) Rustelle Janse van Vuuren et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Microtubule-targeting agents are clinically successful due to both mitotic and interphase impairment of microtubule function
- (2014) Jessica J. Field et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Eribulin mesylate reduces tumor microenvironment abnormality by vascular remodeling in preclinical human breast cancer models
- (2014) Yasuhiro Funahashi et al. CANCER SCIENCE
- Diversity-oriented synthesis as a tool for identifying new modulators of mitosis
- (2014) Brett M. Ibbeson et al. Nature Communications
- Microtubules and Their Role in Cellular Stress in Cancer
- (2014) Amelia L. Parker et al. Frontiers in Oncology
- Molecular Mechanism of Action of Microtubule-Stabilizing Anticancer Agents
- (2013) A. E. Prota et al. SCIENCE
- An Overview of Tubulin Inhibitors That Interact with the Colchicine Binding Site
- (2012) Yan Lu et al. PHARMACEUTICAL RESEARCH
- Microtubule-binding agents: a dynamic field of cancer therapeutics
- (2010) Charles Dumontet et al. NATURE REVIEWS DRUG DISCOVERY
- Overcoming Drug Resistance in Patients with Metastatic Breast Cancer
- (2009) Serena T Wong et al. PHARMACOTHERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started